| Dr Peter U Shen, MD | |
|
14225 Newbrook Dr, Chantilly, VA 20151-2228 | |
| (703) 802-7086 | |
| Not Available |
| Full Name | Dr Peter U Shen |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 31 Years |
| Location | 14225 Newbrook Dr, Chantilly, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629042841 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZH0000X | Pathology - Hematology | 39600 (Colorado) | Primary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 39600 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hartford Hospital | Hartford, CT | Hospital |
| William W Backus Hospital | Norwich, CT | Hospital |
| The Hospital Of Central Connecticut | New britain, CT | Hospital |
| St. Vincent's Medical Center | Bridgeport, CT | Hospital |
| Charlotte Hungerford Hospital | Torrington, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hartford Pathology Associates Pc | 8729989561 | 34 |
News Archive
Using a technology called VirScan to study coronavirus antibody responses in a large cohort of SARS-CoV-2-infected and control individuals, researchers identified epitopes recognized by a large fraction of COVID-19 patients, epitopes cross-reactive with antibodies developed in response to other human coronaviruses, and 10 epitopes likely recognized by neutralizing antibodies.
UC San Francisco has been awarded a five-year, $20 million grant from the U.S. Food and Drug Administration and the National Institutes of Health to study the impacts of new and emerging tobacco products, including e-cigarettes and heated tobacco products, which heat tobacco without combustion.
Pancreatic islet transplantation is a promising therapy for treating type 1 diabetes, but the majority of transplanted cells die soon after they are transplanted.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating SGX942, a first-in-class innate defense regulator, as a treatment for oral mucositis in patients undergoing chemoradiation therapy for head and neck cancer.
› Verified 6 days ago
| Entity Name | Hartford Pathology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063464477 PECOS PAC ID: 8729989561 Enrollment ID: O20040115000745 |
News Archive
Using a technology called VirScan to study coronavirus antibody responses in a large cohort of SARS-CoV-2-infected and control individuals, researchers identified epitopes recognized by a large fraction of COVID-19 patients, epitopes cross-reactive with antibodies developed in response to other human coronaviruses, and 10 epitopes likely recognized by neutralizing antibodies.
UC San Francisco has been awarded a five-year, $20 million grant from the U.S. Food and Drug Administration and the National Institutes of Health to study the impacts of new and emerging tobacco products, including e-cigarettes and heated tobacco products, which heat tobacco without combustion.
Pancreatic islet transplantation is a promising therapy for treating type 1 diabetes, but the majority of transplanted cells die soon after they are transplanted.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating SGX942, a first-in-class innate defense regulator, as a treatment for oral mucositis in patients undergoing chemoradiation therapy for head and neck cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter U Shen, MD 13224 Ladybank Ln, Herndon, VA 20171-4030 Ph: (703) 956-6986 | Dr Peter U Shen, MD 14225 Newbrook Dr, Chantilly, VA 20151-2228 Ph: (703) 802-7086 |
News Archive
Using a technology called VirScan to study coronavirus antibody responses in a large cohort of SARS-CoV-2-infected and control individuals, researchers identified epitopes recognized by a large fraction of COVID-19 patients, epitopes cross-reactive with antibodies developed in response to other human coronaviruses, and 10 epitopes likely recognized by neutralizing antibodies.
UC San Francisco has been awarded a five-year, $20 million grant from the U.S. Food and Drug Administration and the National Institutes of Health to study the impacts of new and emerging tobacco products, including e-cigarettes and heated tobacco products, which heat tobacco without combustion.
Pancreatic islet transplantation is a promising therapy for treating type 1 diabetes, but the majority of transplanted cells die soon after they are transplanted.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating SGX942, a first-in-class innate defense regulator, as a treatment for oral mucositis in patients undergoing chemoradiation therapy for head and neck cancer.
› Verified 6 days ago
Yasmeen Haider, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 14225 Newbrook Dr, Chantilly, VA 20151 Phone: 703-802-6900 | |
Dr. Po Zhao, M.D., PH.D. Pathology Medicare: Medicare Enrolled Practice Location: 14225 Newbrook Dr, Chantilly, VA 20151 Phone: 301-891-5165 | |
Shimareet Kumar, Pathology Medicare: Not Enrolled in Medicare Practice Location: 14225 Newbrook Dr, Chantilly, VA 20151 Phone: 703-802-6900 | |
Joann W Andriko, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 14225 Newbrook Drive, Quest Diagnostics, Chantilly, VA 20151 Phone: 703-802-6900 | |
Dr. Nathan Sherman, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 14225 Newbrook Dr, Chantilly, VA 20151 Phone: 703-802-6900 | |
Dr. Yasmine Mona Hijazi, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 14225 Newbrook Dr, Chantilly, VA 20151 Phone: 703-802-7084 Fax: 703-802-7113 |